• Research only
Retatrutide vs Tirzepatide: how the peptides differ

Retatrutide and Tirzepatide are two synthetic peptides often mentioned together. Both are built on a GIP (glucose-dependent insulinotropic polypeptide) backbone and both are 39 amino acids long. The key difference is how many receptors they activate.
Comparison
| Tirzepatide | Retatrutide | |
|---|---|---|
| Length | 39 amino acids | 39 amino acids |
| Receptors | GIP + GLP-1 | GIP + GLP-1 + glucagon |
| Type | dual agonist | triple agonist |
| Code in the literature | LY3298176 | LY3437943 |
Structure
Both sequences are modified to resist enzymatic breakdown, and a fatty acid chain that binds albumin is attached, so both persist longer in research models than natural incretins.
Research uses
- Receptor pharmacology: how one peptide activates two or three receptors and their relative potency.
- Signalling: cAMP formation and β-arrestin studies in cell lines.
- Comparative studies: dual vs triple agonism in the same model.
- Analytics: HPLC and MS method development for long acylated peptides.
Which one for your study
Studying the GIP–GLP-1 interplay – Tirzepatide. If the glucagon receptor contribution matters too – Retatrutide. Both come with a COA (HPLC ≥ 99%).
All LUXPEPTIDES products are for in-vitro laboratory research only. They are not medicines or food supplements and are not for human or animal use.